Novo Nordisk and OpenAI announce partnership to use AI in drug development and operations
The Facts
- Novo Nordisk and OpenAI announced a strategic partnership on April 14 to use AI across Novo Nordisk's business.
- Novo Nordisk said the partnership will apply OpenAI's technology to drug discovery as well as manufacturing and commercial or corporate operations.
- The companies said AI will be used to analyze complex datasets and identify promising drug candidates.
- Novo Nordisk said the collaboration is intended to reduce the time needed to move from research to delivering treatments to patients.
- Novo Nordisk is the maker of the diabetes and obesity drugs Ozempic and Wegovy.
- Reuters and other outlets said drugmakers are increasingly using AI to speed or streamline parts of drug development and related processes.
- Novo Nordisk did not disclose the financial terms of the partnership.
Context
What will the partnership be used for?
Novo Nordisk said it will use OpenAI's technology across drug discovery and broader operations, including manufacturing, supply chain, distribution and commercial functions, to help employees analyze data and work more efficiently WSJ,Yahoo! Finance,elEconomista.es.
What problem is Novo Nordisk trying to solve with AI?
According to the company, the goal is to find promising drug candidates faster and shorten the path from research to patient access by using AI to process large, complex datasets and test hypotheses more quickly CNBC,Euronews English,Morningstar.
Why is this partnership drawing attention now?
The deal fits into a broader push by pharmaceutical companies to use AI in development and operations, and it comes as Novo Nordisk faces intense competition in the obesity-drug market from Eli Lilly Reuters,Bloomberg Business,CNA.
The receipts — 73 sources
Wire services (5)
ReutersGlobal Banking & Finance ReviewNovo Nordisk Partners with OpenAI to Accelerate Drug Develop...
Independent coverage (68)
The Local DenmarkDenmark's Novo Nordisk signs deal with OpenAI to develop new...
MorningstarWegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed ...
Pulse 2.0Novo Nordisk Partners With OpenAI To Accelerate Drug Discove...
O TEMPOCriadoras do ChatGPT e do Ozempic anunciam parceria para des...
Express PharmaNovo Nordisk announces partnership with OpenAI - Express Pha...
FinboldIs Ozempic maker stock a buy after OpenAI partnership?
NASDAQ Stock MarketNovo Nordisk Partners With OpenAI To Transform Drug Discover...
La Libre.beNovo Nordisk mise sur l'IA et s'associe avec OpenAI, maison ...
gacetadesalud.comNovo Nordisk ficha a OpenAI para acelerar la creación de fár...
euronewsNovo Nordisk alia-se à OpenAI para acelerar investigação de ...
Pharmaceutical TechnologyNovo Nordisk and OpenAI forge alliance to drive speedy drug ...
Euronews EspañolNovo Nordisk y OpenAI aceleran la investigación de fármacos
storyboard18.comNovo Nordisk partners with OpenAI to accelerate AI-led drug ...
Portal TelaNovo Nordisk e OpenAI unem esforços para acelerar pesquisa d...
lecourrier.vnNovo Nordisk signe un partenariat avec OpenAI pour accélerer...
Euronews EnglishNovo Nordisk joins forces with OpenAI to fast-track drug res...
Yahoo NewsNovo Nordisk s'allie à OpenAI pour accélérer la recherche de...
BOLSAMANIANovo Nordisk signs deal with OpenAI to help speed up drug re...
Sciences et AvenirPharmacie et IA : Novo Nordisk noue un partenariat stratégiq...
elEconomista.esNovo Nordisk se alía con OpenAI para ampliar su cartera con ...
O PovoNovo Nordisk anuncia aliança com a OpenAI para o desenvolvim...
FirstpostDanish firm Novo Nordisk joins hands with OpenAI to develop ...
The Cryptonomist¿Acelerará el descubrimiento de fármacos la asociación de in...
The CryptonomistLe partenariat entre Novo Nordisk et OpenAI en matière d'IA ...
The CryptonomistWill novo nordisk ai partnership with OpenAI accelerate drug...
Estrategias de inversiónNovo Nordisk se alía con OpenAI para descubrir medicamentos ...
Yahoo! FinanceGLP-1 giant Novo Nordisk partners with OpenAI as pharma indu...
Economic TimesNovo Nordisk signs deal with OpenAI to develop new drugs - T...
BlockonomiNovo Nordisk (NVO) Teams Up With OpenAI in Major AI Drug Dev...
The PeninsulaNovo Nordisk signs deal with OpenAI to develop new drugs
domain-b.comNovo Nordisk explores AI partnerships to accelerate drug dis...
Daily SabahOzempic-maker Novo Nordisk, OpenAI announce strategic partne...
ExameComo a dona do Ozempic que usar o ChatGPT na corrida contra ...
Proactiveinvestors UKGLP-1 giant Novo Nordisk partners with OpenAI as pharma indu...
BGNES: Breaking News, Latest News and VideosNovo Nordisk signs deal with OpenAI to develop new drugs
ForkLogNovo Nordisk to Integrate OpenAI Technology for Drug Develop...
Investing.comNovo Nordisk partners with OpenAI to speed up drug discovery...
Investing.com EspañolNovo Nordisk se asocia con OpenAI para acelerar el descubrim...
Investing.com FranceNovo Nordisk s'associe à OpenAI pour accélérer la découverte...
Deccan ChronicleNovo Nordisk Taps OpenAI to Speed Development of New Obesity...
TradingViewNovo Nordisk recorre à OpenAI para acelerar uso de IA no des...
MorningstarNovo Nordisk and OpenAI Partner to Speed Drug Discovery
Istoe dinheiroNovo Nordisk anuncia aliança com a OpenAI para o desenvolvim...
europa pressNovo Nordisk se asocia con OpenAI para aprovechar las capaci...
NoticiasDe.esNovo Nordisk se asocia con OpenAI para utilizar las capacida...
The News InternationalOpenAI-Novo Nordisk collaboration signals new era in AI-driv...
NDTVNovo Nordisk Partners With OpenAI To Accelerate Drug Discove...
news24Ozempic, Wegovy owner turns to OpenAI to speed up drug devel...
NewsBytesNovo Nordisk partners with OpenAI to find next breakthrough ...
Medias24 - Site d'informationNovo Nordisk signe un partenariat avec OpenAI pour accélerer...
ABC BourseNovo Nordisk s'allie à OpenAI
The Wall Street JournalNovo Nordisk and OpenAI Partner to Speed Drug Discovery
News.azNovo Nordisk teams up with OpenAI on AI drugs | News.az
CNBCNovo Nordisk partners with OpenAI as AI drug discovery hopes...
Taiwan NewsNovo Nordisk and OpenAI partner to transform how medicines a...
wallstreet:onlineNovo Nordisk and OpenAI partner to transform how medicines a...
The Manila timesNovo Nordisk and OpenAI partner to transform how medicines a...
CNAWegovy-maker Novo Nordisk partners with OpenAI to speed drug...
SiliconANGLEOpenAI partners with Novo Nordisk to accelerate drug discove...
Bloomberg BusinessNovo Taps OpenAI to Speed Development of New Obesity Drugs
Computer WeeklyNovo Nordisk partners with OpenAI to AI-power drug developme...
Yahoo! FinanceAssessing Novo Nordisk (NYSE:NVO) Valuation After Recent Sha...
Taiwan NewsNovo Nordisk A/S - share repurchase programme | Taiwan News ...
The Manila timesNovo Nordisk A/S - share repurchase programme
wallstreet:onlineNovo Nordisk A/S - share repurchase programme
Financial Times NewsWeight-loss drugs and Mars bars: Novo Nordisk's comeback bid
EL PAÍSOzempic se queda sin patente en la India y China, pero Europ...
ExpansiónLas farmacéuticas aceleran en el 'mercado de la obesidad'
The news, read by both sides.
The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.